This article is based on a poster originally authored by Sophie Snow, Kira Freeman, Zaynab Isseljee, Alice Brankin and Christine Sanfelice, which was presented at ELRIG Drug Discovery 2024 in ...

Monoclonal antibody (mAb) therapeutics comprise one of the most rapidly growing drug classes, with over 100 mAbs approved for use by the US FDA. The success of mAbs as a class of therapeutics is ...

Larry Sklar (left) is a Distinguished Professor Emeritus at the University of New Mexico (UNM; NM, USA) whose interest in flow cytometry as a tool for drug discovery led to the development of ...

Recent advances in analytical techniques have increased the efficiency of therapeutic antibody discovery and facilitated rapid growth of the mono-clonal antibody (mAb) market over the past 25 years.

Antibody drugs such as monoclonal antibodies (mAb), bispecific antibodies, antibody-drug conjugates (ADCs), and nanobodies garnered increased interest in research and development circles. Sino ...

Flow cytometry assay validation requires different analytical approaches in preclinical and clinical settings. A fit-for-purpose (FFP) strategy allows researchers to customize the validation to ...

While flow cytometry shines by its flexibility, it requires a high level of expertise in antibody panel development, relies on experienced operators and is often challenged by inconsistent and ...

Flow cytometry is a way to look closely at the features of cells or particles. A sample of blood or tissue goes into a machine called a cytometer. In less than a minute, a computer can analyze ...

LAVAL, Québec--(BUSINESS WIRE)--Altasciences is pleased to announce the completion of its laboratory facilities in Columbia, MO. The newly expanded, 8,000-square-foot space, which includes a test ...